Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 31722-304
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 31722-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Decitabineforinjcartonlabel (Decitabineforinjcartonlabel)
This text appears to be a detailed description of a medication named "Decitabine for Injection" containing 50 mg per vial for intravenous infusion only. It includes important information on storage instructions, reconstitution process, stability, dosage details, and manufacturer's information. The medication is identified as a Cytotoxic Agent and must be kept out of reach of children. The text also mentions different temperature ranges for storage and reconstitution, along with the batch coding details.*
Decitabineforinjstructure (Decitabineforinjstructure)
Decitabineforinjviallabel (Decitabineforinjviallabel)
This is a description for Decitabine for Injection, a cytotoxic agent indicated for intravenous infusion only. Each vial contains 50g of decitabine, along with other components for adjustment. The usual dosage information can be found in the package insert. The product should be stored between 20°C to 25°C. The product is manufactured by Hetero Labs Limited in India for Camber Pharmaceuticals, Inc. Additional details can be found on the packaging batch code area, and for inquiries, a contact number is provided for the U.S. market.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.